Analystreport

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

AcelRx Pharmaceuticals, Inc.  (ACRX) 
Last acelrx pharmaceuticals, inc. earnings: 3/16 07:35 am Check Earnings Report
US:NASDAQ Investor Relations: ir.acelrx.com/investor-relations